Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07682818 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pharmacokinetics of Petrelintide in Participants With Impaired Hepatic Function

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Zealand Pharma
13 trials monitored
See 1 trial at risk
This clinical research trial is testing the investigational medicinal product (IMP) petrelintide that is being developed for body weight reduction in people living with obesity or overweight who have comorbidities. The aim of this clinical research trial is to investigate whether the pharmacokinetics (PK) of petrelintide will be different in people with hepatic impairment (HI) compared to people with normal hepatic function.
Trial Details
NCT Number NCT07682818
Lead Sponsor Zealand Pharma
Conditions
(from sponsor)		 Impaired Hepatic Function
Enrollment 36 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov